𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breast cancer revisited using DNA array-based gene expression profiling

✍ Scribed by François Bertucci; Patrice Viens; Pascal Hingamp; Valery Nasser; Rémi Houlgatte; Daniel Birnbaum


Publisher
John Wiley and Sons
Year
2002
Tongue
French
Weight
441 KB
Volume
103
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Breast cancer is a complex genetic disease characterized by the accumulation of multiple molecular alterations. The resulting clinical heterogeneity makes current diagnostic and therapeutic strategies less than perfectly adapted to each patient. Pathological and clinical factors are insufficient to capture the complex cascade of events that drive the clinical behavior of tumors. High‐throughput molecular technologies provide novel tools to tackle this complexity. In particular, DNA arrays allow the simultaneous and quantitative analysis of the mRNA expression levels of thousands of genes in a single assay. Potential applications are multiple in the cancer field and the first research results are promising; comprehensive gene expression profiles of breast tumors are providing insights into mammary oncogenesis and are revealing new tumor subgroups previously indistinguishable. Significant advances will be the identification of new diagnostic, prognostic and predictive biomarkers as well as the discovery of new potential therapeutic targets. This review presents recent applications of DNA arrays in breast cancer research and discusses some issues to address in the near future to allow the technology to reach its full potential. © 2002 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Modulation of protein expression levels
✍ Ferda Ari; Rudolf Napieralski; Engin Ulukaya; Egemen Dere; Christoph Colling; Ka 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 1 views

Epigenetic drugs are promising add-ons to cancer treatment; still, adverse effects concerning tumour promotion have been reported occasionally. In this in vitro study, we investigated the effect of combination treatment of decitabine with anthracycline-based chemotherapy [5-fluorouracil plus epirub